胸段与复杂腔内主动脉修复中脑脊液引流并发症分析
该回顾性单中心研究纳入2010年1月至2023年10月接受TEVAR或cEVAR并围术期脑脊液引流(CSFD)的251例连续患者,评估CSFD相关并发症的发生率、严重程度及危险因素。主要并发症发生率为4.4%(11/251),均为出血性,其中2例死亡;次要并发症16.7%,头痛7.2%,脊髓缺血4.5%。多变量分析显示较低体重指数与主要CSFD相关并发症相关(OR 0.82,95%CI 0.69-0.97;P=0.022)。
要点
- CSFD相关主要并发症均为出血性,发生率4.4%,死亡2例。
- 较低体重指数与主要CSFD并发症独立相关(OR 0.82,95%CI 0.69-0.97)。
- 预防性引流下脊髓缺血仍达4.5%,需密切神经监测。
核心结论
- CSFD相关并发症常见,主要并发症均为出血性事件。
- 需仔细选择患者、标准化CSFD管理并密切神经监测。
研究设计与样本
- 回顾性单中心研究,纳入2010年1月至2023年10月连续接受TEVAR或cEVAR并围术期CSFD的患者251例(TEVAR 154例,cEVAR 97例)。
- CSFD指征基于机构风险评估,包括主动脉覆盖范围、既往主动脉修复及临床表现。
主要发现
- 主要CSFD相关并发症发生率为4.4%(11/251),均为出血性,其中2例死亡。
- 次要并发症发生率为16.7%,头痛发生率为7.2%。
- 尽管预防性引流,脊髓缺血发生率为4.5%。
- 30天死亡率为8.0%。
- 探索性多变量分析中,较低体重指数与主要CSFD相关并发症相关(OR 0.82,95%CI 0.69-0.97;P=0.022),治疗性CSFD仅在单变量分析中显著。
临床怎么用
- 在胸段与复杂腔内主动脉修复中使用CSFD时,应仔细选择患者并标准化管理。
- 对CSFD患者需密切神经监测,警惕出血性并发症。
局限性
- 回顾性单中心设计。
- 治疗性CSFD样本量小(仅9例仅治疗性,3例预防+治疗性),相关分析受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebrospinal fluid drainage (CSFD) is widely used for neuroprotection during thoracic and complex endovascular aortic repair (TEVAR/cEVAR), yet its safety profile remains incompletely defined. This study evaluated the incidence, severity, and risk factors of CSFD-related complications in clinical practice. METHODS: This retrospective single-center study included consecutive patients undergoing TEVAR or cEVAR with perioperative CSFD between January 2010 and October 2023. The indication for CSFD was based on institutional risk assessment, including extent of aortic coverage, prior aortic repair, and clinical presentation. Primary outcomes were CSFD-associated complications (major, minor, headache). Secondary outcomes included spinal cord ischemia and 30-day mortality. Multivariable logistic regression identified predictors of major complications. RESULTS: A total of 251 patients were included (154 TEVAR and 97 cEVAR); CSFD was applied prophylactically in 239 patients only, therapeutically in 9 patients only, and both prophylactically and therapeutically in 3 patients. The median age was 69 years, and 53.8% had prior aortic surgery. Major CSFD-related complications occurred in 4.4% (11/251), all hemorrhagic, with mortality in 2 patients. Minor complications occurred in 16.7%, and headache in 7.2%. Spinal cord ischemia developed in 4.5% despite prophylactic drainage. In exploratory multivariable analysis, lower body mass index was associated with major CSFD-associated complications (odds ratio: 0.82, 95% confidence interval: 0.69-0.97; P = 0.022), whereas therapeutic CSFD was significant only in univariable analysis. Thirty-day mortality was 8.0%. CONCLUSION: CSFD-associated complications were common, with hemorrhagic events accounting for all major complications. These findings emphasize the need for careful patient selection, standardized CSFD management, and close neurological monitoring when CSFD is used during complex endovascular aortic repair.
引用
- Hagedorn MN, Hashimi S, Bresler AM, et al. Complications of Cerebrospinal Fluid Drainage in Thoracic and Complex Endovascular Aortic Repair. Ann Vasc Surg. 2026. PMID: 42710833. doi:10.1016/j.avsg.2026.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。